Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-23-028563)

Filing Details

Accession Number:: 0001493152-23-028563
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-14 16:38:28
Reporting Period:: 2023-08-11

Accepted Time:: 2023-08-14 16:38:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1862150	Cingulate Inc.	CING	Pharmaceutical Preparations (2834)	863825535

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1883257	J. Peter Werth	1901 W. 47Th Place Kansas City KS 66205		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-11	1,823,155	$0.55	2,798,320	No	4	P	Indirect	By Werth Family Investment Associates LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Werth Family Investment Associates LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	21,849	Direct

Footnotes

The purchase was made in a private transaction with the Issuer that closed on August 11, 2023.
Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.